Short Interest in GlucoTrack, Inc. (NASDAQ:GCTK) Increases By 53.5%

GlucoTrack, Inc. (NASDAQ:GCTK) saw a large increase in short interest in the month of March. As of March 13th, there was short interest totaling 43,428 shares, an increase of 53.5% from the February 26th total of 28,292 shares. Currently, 4.4% of the company’s stock are short sold. Based on an average daily volume of 48,922 shares, the days-to-cover ratio is presently 0.9 days.

Wall Street Analyst Weigh In

Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of GlucoTrack in a research note on Thursday, January 22nd. One research analyst has rated the stock with a Sell rating, According to MarketBeat.com, the stock currently has an average rating of “Sell”.

Institutional Trading of GlucoTrack

A number of hedge funds have recently made changes to their positions in GCTK. Bank of America Corp DE increased its position in GlucoTrack by 102,125.0% during the 2nd quarter. Bank of America Corp DE now owns 4,089 shares of the company’s stock valued at $25,000 after buying an additional 4,085 shares in the last quarter. Boothbay Fund Management LLC bought a new stake in GlucoTrack in the fourth quarter worth $52,000. Finally, Ikarian Capital LLC purchased a new stake in shares of GlucoTrack in the fourth quarter worth $177,000. 10.92% of the stock is owned by institutional investors.

GlucoTrack Stock Performance

NASDAQ:GCTK opened at $0.99 on Monday. The firm has a market capitalization of $1.00 million, a P/E ratio of -0.03 and a beta of 0.33. The company has a debt-to-equity ratio of 0.08, a current ratio of 1.53 and a quick ratio of 1.53. GlucoTrack has a one year low of $0.96 and a one year high of $15.90. The company’s 50-day simple moving average is $1.83 and its 200 day simple moving average is $4.39.

About GlucoTrack

GlucoTrack, Inc, a medical device company, focused on the design, development, and commercialization of novel technologies for people with diabetes in the United States. It develops GlucoTrack, a noninvasive glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain. The company was formerly known as Integrity Applications, Inc and changed its name to GlucoTrack, Inc in November 2021. GlucoTrack, Inc was founded in 2001 and is based in Rutherford, New Jersey.